142 related articles for article (PubMed ID: 1656657)
1. Maternal antibodies against equine influenza virus in foals and their interference with vaccination.
Van Oirschot JT; Bruin G; de Boer-Luytze E; Smolders G
Zentralbl Veterinarmed B; 1991 Jul; 38(5):391-6. PubMed ID: 1656657
[TBL] [Abstract][Full Text] [Related]
2. Interference of maternal antibodies with the immune response of foals after vaccination against equine influenza.
van Maanen C; Bruin G; de Boer-Luijtze E; Smolders G; de Boer GF
Vet Q; 1992 Jan; 14(1):13-7. PubMed ID: 1574831
[TBL] [Abstract][Full Text] [Related]
3. Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine.
Minke JM; Toulemonde CE; Dinic S; Cozette V; Cullinane A; Audonnet JC
J Comp Pathol; 2007 Jul; 137 Suppl 1():S76-80. PubMed ID: 17559865
[TBL] [Abstract][Full Text] [Related]
4. Duration of maternally derived antibodies against equine influenza in newborn foals.
Liu IK; Pascoe DR; Chang LW; Zee YC
Am J Vet Res; 1985 Oct; 46(10):2078-80. PubMed ID: 4062009
[TBL] [Abstract][Full Text] [Related]
5. Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination.
Wilson WD; Mihalyi JE; Hussey S; Lunn DP
Equine Vet J; 2001 Nov; 33(7):644-50. PubMed ID: 11770984
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.
Tallmadge RL; Miller SC; Parry SA; Felippe MJB
PLoS One; 2017; 12(5):e0177831. PubMed ID: 28520789
[TBL] [Abstract][Full Text] [Related]
7. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings.
Cullinane A; Weld J; Osborne M; Nelly M; Mcbride C; Walsh C
Vet J; 2001 Mar; 161(2):174-85. PubMed ID: 11243687
[TBL] [Abstract][Full Text] [Related]
8. An updated equine influenza vaccine and an equine influenza-herpesvirus combination vaccine containing an immunostim adjuvant provoke equal antibody levels in young foals throughout the primary vaccination course.
Heldens JG; Van de Wouw JC; Van Loon AA
Vet J; 2002 Nov; 164(3):288-91. PubMed ID: 12505406
[No Abstract] [Full Text] [Related]
9. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
Heldens JG; Pouwels HG; van Loon AA
Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
[TBL] [Abstract][Full Text] [Related]
10. Duration of immunity induced by an adjuvanted and inactivated equine influenza, tetanus and equine herpesvirus 1 and 4 combination vaccine.
Heldens JG; Kersten AJ; Weststrate MW; van den Hoven R
Vet Q; 2001 Nov; 23(4):210-7. PubMed ID: 11765243
[TBL] [Abstract][Full Text] [Related]
11. Field study of the safety, immunogenicity, and efficacy of an inactivated equine rotavirus vaccine.
Powell DG; Dwyer RM; Traub-Dargatz JL; Fulker RH; Whalen JW; Srinivasappa J; Acree WM; Chu HJ
J Am Vet Med Assoc; 1997 Jul; 211(2):193-8. PubMed ID: 9227750
[TBL] [Abstract][Full Text] [Related]
12. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8).
Newton JR; Townsend HG; Wood JL; Sinclair R; Hannant D; Mumford JA
Equine Vet J; 2000 Jan; 32(1):65-74. PubMed ID: 10661388
[TBL] [Abstract][Full Text] [Related]
13. Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).
Mumford J; Wood JM; Scott AM; Folkers C; Schild GC
J Hyg (Lond); 1983 Jun; 90(3):385-95. PubMed ID: 6306098
[TBL] [Abstract][Full Text] [Related]
14. [Equine influenza in Czechoslovakia during the 1973 epizootic].
Zakopal J; Pour L
Vet Med (Praha); 1975 Sep; 20(9):555-60. PubMed ID: 814680
[TBL] [Abstract][Full Text] [Related]
15. Detection of antibodies to the nonstructural protein (NS1) of influenza A virus allows distinction between vaccinated and infected horses.
Ozaki H; Sugiura T; Sugita S; Imagawa H; Kida H
Vet Microbiol; 2001 Sep; 82(2):111-9. PubMed ID: 11423202
[TBL] [Abstract][Full Text] [Related]
16. Passive transfer, rate of decay, and protein specificity of antibodies against equine arteritis virus in horses from a Standardbred herd with high seroprevalence.
Hullinger PJ; Wilson WD; Rossitto PV; Patton JF; Thurmond MC; MacLachlan NJ
J Am Vet Med Assoc; 1998 Sep; 213(6):839-42. PubMed ID: 9743724
[TBL] [Abstract][Full Text] [Related]
17. Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression.
Lunn DP; Hussey S; Sebing R; Rushlow KE; Radecki SV; Whitaker-Dowling P; Youngner JS; Chambers TM; Holland RE; Horohov DW
J Am Vet Med Assoc; 2001 Mar; 218(6):900-6. PubMed ID: 11294315
[TBL] [Abstract][Full Text] [Related]
18. Surveillance for immunity against equine influenza virus infections.
Bürki F; Lamatsch O
Comp Immunol Microbiol Infect Dis; 1981; 4(3-4):267-78. PubMed ID: 6174266
[No Abstract] [Full Text] [Related]
19. Effect of influenza A/equine/H3N8 virus isolate variation on the measurement of equine antibody responses.
Bogdan JR; Morley PS; Townsend HG; Haines DM
Can J Vet Res; 1993 Apr; 57(2):126-30. PubMed ID: 8387870
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge.
Pouwels HG; Van de Zande SM; Horspool LJ; Hoeijmakers MJ
Vet Rec; 2014 Jun; 174(25):633. PubMed ID: 24795071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
